KNCV Strategic Priorities

KNCV has identified three strategic priorities to maximize its impact in the fight against TB and related health challenges. These priorities are informed by the organization’s competencies, global health trends, and the needs of affected communities.

Strategic Priority 1: Implementation Science, Innovation, Demonstration & Scale-Up

 

KNCV advances the fight against TB through science-led innovation, piloting, and validating novel interventions to assess real-world feasibility and inform scalable impact.

 

Nurse hands on pillbox

Objectives

Examples of impact

  • Prevention: KNCV co-led introduction of 3HP and 1HP regimens, generating evidence for global uptake.
  • Treatment: KNCV co-developed WHO’s aDSM framework, enabling safer roll-out of new regimens such as BPaL/M.
  • Adherence: KNCV operationalized electronic pillboxes and chatbots to empower patients and improve adherence.

Strategic Priority 2: Health & Community System Strengthening

 

KNCV strengthens global health systems to ensure effective, resilient TB services, a need that has grown amid funding disruptions. Its science-led approach aligns with WHO’s health system building blocks.

 

Nigeria - Smile - man woman

Objectives

Examples of impact

Since 2019, KNCV has supported over 10 countries in developing evidence-based, prioritized, and costed National Strategic Plans (NSPs), aligned with the WHO Global End TB Strategy and Universal Health Coverage (UHC) goals.

Strategic Priority 3: Knowledge & Capacity Exchange

 

KNCV functions as a global hub for knowledge exchange, convening stakeholders to accelerate learning and collective action toward ending TB.

 

Shree - Global Health & SRHR EVENT Photo Almicheal Fraay (@maikeljay)-70.jpg

MPI: Dr. Vijayashree Yellappa at Global Health & SRHR Event. Photo Credits: Almicheal Fraay

Objectives

Offerings:

  • TB & Cross-disease Care Continuum: Hosting curated e-campus/knowledge platform to host KNCV’s tools, training materials, publications, and case studies, potentially in partnership with academic institutions.
  • Collaborate with European NGOs on TB advocacy and funding.
  • Facilitate cross-program collaboration among global (Gavi, WHO, the Global Fund) and national interest-holders to reduce fragmentation.
  • Health, Climate, Gender and Nutrition:  Lead forums with civil society, gender experts, and nutrition specialists to embed equity and inrtersectionality in TB programming.